[Federal Register Volume 75, Number 41 (Wednesday, March 3, 2010)]
[Notices]
[Page 9615]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4404]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances Notice of Registration
By Notice dated October 21, 2009, and published in the Federal
Register on October 28, 2009, (74 FR 55588), Johnson Matthey Inc.,
Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New
Jersey 08066-1742, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)............................. I
Tetrahydrocannabinols (7370)................................. I
Dihydromorphine (9145)....................................... I
Difenoxin (9168)............................................. I
Propiram (9649).............................................. I
Amphetamine (1100)........................................... II
Methamphetamine (1105)....................................... II
Lisdexamfetamine (1205)...................................... II
Methylphenidate (1724)....................................... II
Nabilone (7379).............................................. II
Cocaine (9041)............................................... II
Codeine (9050)............................................... II
Dihydrocodeine (9120)........................................ II
Oxycodone (9143)............................................. II
Hydromorphone (9150)......................................... II
Ecgonine (9180).............................................. II
Hydrocodone (9193)........................................... II
Meperidine (9230)............................................ II
Methadone (9250)............................................. II
Methadone intermediate (9254)................................ II
Morphine (9300).............................................. II
Thebaine (9333).............................................. II
Oxymorphone (9652)........................................... II
Noroxymorphone (9668)........................................ II
Alfentanil (9737)............................................ II
Remifentanil (9739).......................................... II
Sufentanil (9740)............................................ II
Fentanyl (9801).............................................. II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for sale to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Johnson Matthey Inc. to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Johnson Matthey Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: February 24, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-4404 Filed 3-2-10; 8:45 am]
BILLING CODE 4410-09-P